Wnt–β-catenin: signaling through controlled protein stability

In one sentence

Canonical Wnt signaling changes the control of β-catenin breakdown, allowing β-catenin to help regulate gene expression.

The intuition

Imagine a message carrier that is normally removed quickly. A signal lets more of the carrier remain and reach a control room. In canonical Wnt signaling, regulated β-catenin stability helps carry the message. β-catenin also has a separate role at cell junctions, so its location matters.

How it works

Wnt ligands are secreted signaling proteins. In canonical signaling, they engage a receptor system involving Frizzled and a co-receptor. This changes how the cell handles the protein β-catenin.

Without an effective Wnt signal, a destruction complex helps phosphorylate β-catenin and mark it for ubiquitin-dependent degradation. Phosphorylation means attaching a phosphate group. Proteins including Axin and adenomatous polyposis coli (APC) organize this regulation. Experiments identified sequential kinase steps that prepare β-catenin for destruction. Liu 2002.

With canonical Wnt signaling, β-catenin can accumulate and enter the nucleus, where it works with transcription-regulating proteins. This can change genes involved in cell identity and growth. Wnt proteins can also signal through routes that do not use β-catenin; this page concerns the canonical route.

PORCN is an enzyme involved in modification of Wnt ligands needed for their secretion. Inhibiting this upstream step can reduce ligand-dependent signaling. It need not overcome a downstream alteration that keeps β-catenin active without the ligand.

Why it matters in cancer

A cancer may alter the ligand supply, receptor system, destruction complex, or another regulatory step. These alterations are not interchangeable. The intervention has to fit where the signal originates and what keeps it active.

A fall in a pathway-responsive transcript can establish a biochemical response. It does not establish that the tumor shrinks or that normal tissues can tolerate the intervention.

A worked example

Two fictional cultures have nuclear β-catenin. Culture A loses the signal when Wnt ligand secretion is blocked. Culture B retains it because a downstream control is disrupted in the model.

A supports an upstream ligand-dependent hypothesis. B points toward a different source of activation. Neither finding alone demonstrates selective killing. Measuring viability and using independent controls remain separate tasks.

Common confusions

All Wnt versus canonical Wnt: β-catenin is not the readout for every Wnt route.
Total versus nuclear β-catenin: the protein also participates in cell adhesion.
Pathway activity versus ligand dependence: a downstream change can bypass an upstream intervention.
Target engagement versus response: altering a transcript is not the same outcome as improving patient health.

How it is measured

Research assays can examine β-catenin localization, responsive transcripts such as AXIN2, and transcriptional reporters. Compare before and after a defined perturbation. Each readout has limits, including cell composition and effects on transcription more broadly. A phase I WNT974 study illustrates why tissue target engagement and clinical response must be reported separately. Rodon 2021.

Ubiquitin and the proteasome explains protein turnover. Notch signaling supplies a neighboring developmental pathway. The signaling lesson compares where different interventions act.

Sources

Source check: 2026-10-09. General mechanism education; the worked example is fictional. Expert and learner review pending.